NCT01088932View on ClinicalTrials.gov

Multiple Dose Safety Study of SRX246 Capsules in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

March 31, 2010

Primary Completion Date

June 30, 2010

Study Completion Date

July 31, 2010

Conditions
Healthy
Interventions
DRUG

SRX246

capsules

Trial Locations (1)

21201

SNBL Clinical Pharmacology Center, Baltimore

Sponsors
All Listed Sponsors
lead

Azevan Pharmaceuticals

INDUSTRY

NCT01088932 - Multiple Dose Safety Study of SRX246 Capsules in Healthy Volunteers | Biotech Hunter | Biotech Hunter